ONYX PHARMACEUTICALS INC Financing Cash Flow
ONYX PHARMACEUTICALS INC reported Financing Cash Flow of $25.48 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2012-08-06
- ONYX PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2012-06-30 was $19.06M, a 197.32% increase year-over-year.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2012-03-31 was $6.42M, a 21.79% increase year-over-year.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-12-31 was $9.91M, a 217.62% increase year-over-year.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2011-09-30 was $1.77M, a 11.60% increase year-over-year.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2011 was $23.37M, a 178.29% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2010 was $8.40M, a 97.57% decline from fiscal 2009.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2009 was $345.65M, a 13276.63% increase from fiscal 2008.
- ONYX PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2008 was $2.58M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | $19.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $25.48M 10-Q · filed 2012-08-06 | $35.40M derived: sum of 3 quarters · filed 2012-08-06 | $37.17M derived: sum of 4 quarters · filed 2012-08-06 |
| 2012-03-31 | $6.42M 10-Q · filed 2012-05-04 | $16.34M derived: sum of 2 quarters · filed 2012-05-04 | $18.11M derived: sum of 3 quarters · filed 2012-05-04 | $24.52M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-12-31 | $9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $11.68M derived: sum of 2 quarters · filed 2012-02-27 | $18.09M derived: sum of 3 quarters · filed 2012-08-06 | $23.37M 10-K · filed 2012-02-27 |
| 2011-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $8.18M derived: sum of 2 quarters · filed 2012-08-06 | $13.46M 10-Q · filed 2011-11-03 | $16.58M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-06-30 | $6.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $11.69M 10-Q · filed 2012-08-06 | $14.81M derived: sum of 3 quarters · filed 2012-08-06 | $16.39M derived: sum of 4 quarters · filed 2012-08-06 |
| 2011-03-31 | $5.27M 10-Q · filed 2012-05-04 | $8.39M derived: sum of 2 quarters · filed 2012-05-04 | $9.98M derived: sum of 3 quarters · filed 2012-05-04 | $10.74M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $4.71M derived: sum of 2 quarters · filed 2012-02-27 | $5.46M derived: sum of 3 quarters · filed 2012-02-27 | $8.40M 10-K · filed 2012-02-27 |
| 2010-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $2.34M derived: sum of 2 quarters · filed 2011-11-03 | $5.28M 10-Q · filed 2011-11-03 | -$649.00K derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $758.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $3.69M 10-Q · filed 2011-08-09 | -$2.23M derived: sum of 3 quarters · filed 2012-02-27 | $357.23M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $2.93M 10-Q · filed 2011-05-10 | -$2.99M derived: sum of 2 quarters · filed 2012-02-27 | $356.47M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-31 | -$5.92M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $353.54M derived: sum of 2 quarters · filed 2012-02-27 | $345.65M 10-K · filed 2012-02-27 | |
| 2009-09-30 | $359.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | $351.58M 10-Q · filed 2010-11-03 | ||
| 2009-06-30 | -$7.89M 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | $2.58M 10-K · filed 2011-02-23 |